| Analysis | Metabolite Name | Measured Value | Units | Group |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.2715 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.3902 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.4307 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.4618 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.4855 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.4973 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.5014 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.5279 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.5416 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.5616 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.5894 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.5928 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.5939 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.6019 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.6124 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.6142 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.6277 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.6333 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.6573 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.6671 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.6757 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.6842 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.6870 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.6945 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.6958 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.6987 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.7002 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.7035 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.7062 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.7106 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.7243 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.7259 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.7336 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.7772 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.7784 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.7835 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.7916 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.7933 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.7934 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.7997 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.8046 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.8080 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.8140 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.8224 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.8254 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.8271 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.8282 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.8353 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.8435 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.8627 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.8669 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.8748 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.8758 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.8892 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.8982 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.9197 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.9279 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.9288 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.9418 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.9493 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.9537 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.9585 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.9653 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.9924 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 0.9962 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0000 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0047 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0229 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0246 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0293 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0324 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0403 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0467 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0598 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0647 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0822 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0852 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0855 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0862 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0889 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0921 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.0934 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1046 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1058 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1062 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1141 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1151 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1255 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1427 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1457 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1484 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1525 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1528 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1552 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1613 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1617 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1761 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1926 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.1934 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.2145 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.2234 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.2335 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.2344 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.2376 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.2380 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.2414 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.2579 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.2975 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.3288 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.3380 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.3452 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.3777 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.4079 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.4217 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.4238 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.4705 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.4861 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.5163 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.5381 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.5530 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.5582 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.6176 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.6351 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.7370 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.7488 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.7720 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.7741 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 1.8846 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 2.1710 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | margarate (17:0) | 2.3712 | Peak area | Obese non neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|